Discover 1,670 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,670
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Eatontown NJ, Jersey City NJ, Brooklyn NY, Bethlehem PA,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase 2, Phase 3, Recruiting
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for
Neovascular Age-related Macular Degeneration
Location: Little Silver NJ, Philadelphia PA, Towson MD,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07007065
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Staten Island NY, Northfield NJ, Hawthorne NY,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase 3, Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
for
Primary Immune Thrombocytopenia (ITP)
Location: Little Silver NJ, New Haven CT, Washington D.C. DC,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06544499
Phase 3, Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18 - 70+
Code: NCT06843525
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.